1. Pink Sheet
  2. >>Geography
  3. >>Europe

Sputnik V Vaccine Team ‘Working With EMA To Start Rolling Review’

 
• By Ian Schofield

After a few false starts, it seems that the EU regulator has begun preparing the ground for a review of Russia’s adenovirus-based COVID-19 vaccine.

Concept of russian vaccine against COVID-19. Glass medical vials with liquid.
Is the Sputnik V review finally taking off in Europe? • Source: Shutterstock

The European Medicines Agency has appointed rapporteurs for the evaluation of the Russian Sputnik V coronavirus vaccine and its developers are “waiting for EMA to begin the rolling review and announce it officially on its web site,” according to the Russian Direct Investment Fund, which is financing the development of the vaccine.

“Following the submission of request for rolling review that was received by EMA, RDIF is working with EMA to start the rolling review for Sputnik V,” the vaccine’s Twitter account tweeted on 19

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

Inclusive By Design: UK Pilots Diversity Plans For Drug & Device Trials

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

UK’s International Recognition Procedure: EU Dossier Faster Than US Or Canada

 
• By Eliza Slawther

Companies that use the European Medicines Agency as a reference regulator for the UK’s International Recognition Procedure can expect a faster approval than those that use other national regulators, such as those in the US and Canada, an MHRA spokesperson has said.

FDA Use Of Artificial Intelligence Will Help US Retain Biotech Leadership

 
• By Sue Sutter and Derrick Gingery

At a House subcommittee hearing, HHS Secretary Robert F. Kennedy Jr. rebutted lawmaker concerns that NIH cuts will drive research and scientists to other countries and said he does not want to advise parents on vaccinating children for measles, chickenpox or polio.